Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity—Current Status and Expected Future Trends by Zsolt Ráduly, Robert G. Price, Mark E. C. Dockrell, László Csernoch, István Pócsi

Get full text

Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study by Ian Pavord, Robert Chan, Nicola Brown, Peter Howarth, Martyn Gilson, Robert G. Price, Jorge Maspero

Get full text

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab by Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey

Get full text

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs by Zsolt Ráduly, Zsolt Ráduly, Zsolt Ráduly, András Szabó, András Szabó, Miklós Mézes, Miklós Mézes, Ildikó Balatoni, Robert G. Price, Mark E. Dockrell, Mark E. Dockrell, István Pócsi, László Csernoch

Get full text

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study by Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth

Get full text